2011
DOI: 10.1002/jps.22480
|View full text |Cite
|
Sign up to set email alerts
|

Sustained-Release and Swelling Characteristics of Xanthan Gum/Ethylcellulose-Based Injection Moulded Matrix Tablets: in Vitro and in Vivo Evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(10 citation statements)
references
References 29 publications
0
10
0
Order By: Relevance
“…As a commonly used alternative plasticizer, dibutyl sebacate has been well documented. [2][3][4]19) However, our previous studies on phthalate esters demonstrated that not only DBP but also phthalate esters with short chain alcohol exhibited adjuvant effect. 6,7) As to sebacate esters, there is a report of Twenty-four hours after skin application of 0.5% FITC in acetone alone, or in acetone containing 50% DBP (positive control) or 20% DIPS, cells in the draining lymph nodes were analyzed as to the levels of FITC (abscissa) and CD11c (ordinate) by flow cytometry.…”
Section: )mentioning
confidence: 96%
See 1 more Smart Citation
“…As a commonly used alternative plasticizer, dibutyl sebacate has been well documented. [2][3][4]19) However, our previous studies on phthalate esters demonstrated that not only DBP but also phthalate esters with short chain alcohol exhibited adjuvant effect. 6,7) As to sebacate esters, there is a report of Twenty-four hours after skin application of 0.5% FITC in acetone alone, or in acetone containing 50% DBP (positive control) or 20% DIPS, cells in the draining lymph nodes were analyzed as to the levels of FITC (abscissa) and CD11c (ordinate) by flow cytometry.…”
Section: )mentioning
confidence: 96%
“…Another type of aliphatic plasticizers is sebacate esters, which are applied for medical devices as well as drug formulation. [2][3][4] We have been investigating phthalate esters from an immuno-toxicological point of view. We showed that contact sensitization to fluorescein isothiocyanate (FITC) is enhanced in the presence of certain types of phthalate esters in mouse models.…”
mentioning
confidence: 99%
“…The paddle speed was set at 50 rpm, while the temperature of the medium was maintained at 37±0.5°C. Samples of 5 mL were withdrawn at specific time points (0.5, 1, 2, 4,6,8,12,16,20, and 24 h without media replacement) and spectro-photometrically assessed by means of a double beam spectrophotometer (UV-1650PC, Shimadzu, Belgium; λ max MPT, MPS and MPF was 222, 222 and 220 nm respectively). The MPT, MPF or MPS content in the samples was determined by linear regression.…”
Section: In Vitro Drug Releasementioning
confidence: 99%
“…In these studies, drug release from IM tablets was sustained using ethylcellulose as matrix former and using various hydrophilic fillers (hydroxypropylmethylcellulose, lowsubstituted hydroxypropylcellulose, polyethylene oxide and xanthan gum) to control the release rate. Only the use of xanthan gum resulted in zero-order release; and for all these systems, drug was released by a combination of polymer swelling, Fickian diffusion and matrix erosion (4)(5)(6)(7). In addition, hot melt methods (i.e.…”
Section: Introductionmentioning
confidence: 99%
“…While sustained drug release can be achieved based on the design of the dosage form (reservoir systems vs. matrices) and/or the physicochemical properties of the polymeric materials incorporated in the formulation (diffusion controlled vs. delayed polymer dissolution), hot melt extrusion (HME) (possibly in combination with injection molding) has been evaluated to manufacture sustainedrelease matrices using various polymers: ethylcellulose (EC) [1][2][3], hydroxypropyl (methyl) cellulose (HP(M)C) [4], ethylene vinyl acetate (EVA) [5][6], polyvinyl acetate (PVA) [7], poly lactic (co-glycolic) acid (PL(G)A) [8][9], silicone [10], polycaprolactone (PCL) [11][12], polyoxazolines [13], polyanhydrides [14], methacrylate copolymers (Eudragit ® RS/RL) [15][16], and several lipid materials [17][18][19]. While sustained-release dosage forms have been successfully developed via HME using these polymers, a common drawback is that the drug load in these formulations is often low, either linked to processing issues during HME of formulations with a high drug load, or due to a significant burst release when less polymeric matrix former is incorporated in the formulation.…”
Section: Introductionmentioning
confidence: 99%